The Effect of Adiponectin on the Regulation of Filaggrin Expression in Normal Human Epidermal Keratinocytes
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Adiponectin, an adipokine secreted from adipocytes, affects energy metabolism and also shows anti-diabetic and anti-inflammatory properties. Recent studies have reported that adiponectin plays a role in regulating skin inflammation. Objective: This study aimed to investigate the effect of adiponectin on the expression of filaggrin (FLG) in normal human epidermal keratinocytes (NHEKs). Methods: NHEKs were serum-starved for 6h before being treated with adiponectin. Afterward, cell viability was assessed by MTT assay. We also treated with calcium, interleukin (IL)-4, and IL-13 to provide positive and negative comparative controls, respectively. Gene mRNA expression was quantified using real time reverse transcription polymerase chain reaction, and protein expression was evaluated using Western blot. To evaluate the relationship among mitogen-activated protein kinases (MAPKs), activator protein 1 (AP-1), and FLG, we also treated cells with inhibitors for MAPKs JNK, p38, and ERK1/2. Results: FLG and FLG-2 mRNA expression in NHEKs significantly increased after treatment with 10 μg/ml adiponectin. Adiponectin also restored FLG and FLG-2 mRNA expression that was otherwise inhibited by treatment with IL-4 and IL-13. Adiponectin induced FLG expression via AP-1 and MAPK signaling. Conclusion: Adiponectin positively regulated the expression of FLG and could be useful as a therapeutic agent to control diseases related to disrupted skin barrier function.
Abstract
Background: Adiponectin, an adipokine secreted from adipocytes, affects energy metabolism and also shows anti-diabetic and anti-inflammatory properties. Recent studies have reported that adiponectin plays a role in regulating skin inflammation. Objective: This study aimed to investigate the effect of adiponectin on the expression of filaggrin (FLG) in normal human epidermal keratinocytes (NHEKs). Methods: NHEKs were serum-starved for 6h before being treated with adiponectin. Afterward, cell viability was assessed by MTT assay. We also treated with calcium, interleukin (IL)-4, and IL-13 to provide positive and negative comparative controls, respectively. Gene mRNA expression was quantified using real time reverse transcription polymerase chain reaction, and protein expression was evaluated using Western blot. To evaluate the relationship among mitogen-activated protein kinases (MAPKs), activator protein 1 (AP-1), and FLG, we also treated cells with inhibitors for MAPKs JNK, p38, and ERK1/2. Results: FLG and FLG-2 mRNA expression in NHEKs significantly increased after treatment with 10 μg/ml adiponectin. Adiponectin also restored FLG and FLG-2 mRNA expression that was otherwise inhibited by treatment with IL-4 and IL-13. Adiponectin induced FLG expression via AP-1 and MAPK signaling. Conclusion: Adiponectin positively regulated the expression of FLG and could be useful as a therapeutic agent to control diseases related to disrupted skin barrier function.
참고문헌 (33)
- Scherer PE, "A novel serum protein similar to C1q, produced exclusively in adipocytes", J Biol Chem, 270, pp.26746~26749 (1995)
- Weyer C, "Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia", J Clin Endocrinol Metab, 86, pp.1930~1935 (2001)
- Weiss R, "The "obese insulin-sensitive" adolescent:importance of adiponectin and lipid partitioning", J Clin Endocrinol Metab, 90, pp.3731~3737 (2005)
- Goldstein BJ, "Adiponectin: a novel adipokine linking adipocytes and vascular function", J Clin Endocrinol Metab, 89, pp.2563~2568 (2004)
- Magge SN, "Adiponectin is associated with favorable lipoprotein profile, independent of BMI and insulin resistance, in adolescents", J Clin Endocrinol Metab, 96, pp.1549~1554 (2011)
- Ouchi N, "Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway", Circulation, 102, pp.1296~1301 (2000)
- Salathia NS, "An in vivo screen of secreted proteins identifies adiponectin as a regulator of murine cutaneous wound healing", J Invest Dermatol, 133, pp.812~821 (2013)
- Shibata S, "Adiponectin regulates cutaneous wound healing by promoting keratinocyte proliferation and migration via the ERK signaling pathway", J Immunol, 189, pp.3231~3241 (2012)
- Takahashi H, "Adiponectin and leptin modulate cell proliferation and cytokine secretion of normal human keratinocytes and T lymphocytes", J Dermatol Sci, 59, pp.143~145 (2010)
- Kawai K, "Effects of adiponectin on growth and differentiation of human keratinocytes--implication of impaired wound healing in diabetes", Biochem Biophys Res Commun, 374, pp.269~273 (2008)
- Shibata S, "Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from γδ-T cells", Nat Commun, 6, pp.7687~ (2015)
- Wolk K, "Adipokines in psoriasis: an important link between skin inflammation and metabolic alterations", Rev Endocr Metab Disord, 17, pp.305~317 (2016)
- Fang CL, "Dermal lipogenesis inhibits adiponectin production in human dermal fibroblasts while exogenous adiponectin administration prevents against UVA-induced dermal matrix degradation in human skin", Int J Mol Sci, 17, pp.E1129~ (2016)
- Kim EJ, "UV-induced inhibition of adipokine production in subcutaneous fat aggravates dermal matrix degradation in human skin", Sci Rep, 6, pp.25616~ (2016)
- Harding CR, "Filaggrin - revisited", Int J Cosmet Sci, 35, pp.412~423 (2013)
- Palmer CN, "Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis", Nat Genet, 38, pp.441~446 (2006)
- Thyssen JP, "Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis", J Allergy Clin Immunol, 134, pp.792~799 (2014)
- 진태원, "Adiponectin Upregulates Filaggrin Expression via SIRT1-Mediated Signaling in Human Normal Keratinocytes", Annals of Dermatology, 29(4), pp.407~413 (2017), 대한피부과학회
- Hansen MB, "Re-examination and further development of a precise and rapid dye method for measuring cell growth", cell kill, 1989, pp.119, 203~210
- Rajapakse N, "Inhibition of inducible nitric oxide synthase and cyclooxygenase‐2 in lipopolysaccharide‐stimulated RAW264.7 cells by carboxybutyrylated glucosamine takes place via down‐regulation of mitogen‐activated protein kinase‐mediated nuclear factorkappaB signaling", Immunology, 123, pp.348~357 (2008)
- Candi E, "The cornified envelope: a model of cell death in the skin", Nat Rev Mol Cell Biol, 6, pp.328~340 (2005)
- Howell MD, "Cytokine modulation of atopic dermatitis filaggrin skin expression", J Allergy Clin Immunol, 124, pp.R7~R12 (2009)
- Pellerin L, "Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin", J Allergy Clin Immunol, 131, pp.1094~1102 (2013)
- Paus R, "What are subcutaneous adipocytes really good for...?", Exp Dermatol, 16, pp.45~47 (2007)
- Sandilands A, "Filaggrin in the frontline: role in skin barrier function and disease", J Cell Sci, 122, pp.1285~1294 (2009)
- Hsu CY, "Deimination of human filaggrin-2 promotes its proteolysis by calpain 1", J Biol Chem, 286, pp.23222~23233 (2011)
- Wu Z, "Molecular identification and expression analysis of filaggrin-2, a member of the S100 fused-type protein family", PLoS One, 4, pp.e5227~ (2009)
- Kim M, "Adiponectin suppresses UVB-induced premature senescence and hBD2overexpression in human keratinocytes", PLoS One, 11, pp.e0161247~ (2016)
- Mehic D, "Fos and jun proteins are specifically expressed during differentiation of human keratinocytes", J Invest Dermatol, 124, pp.212~220 (2005)
- Hess J, "AP-1 subunits: quarrel and harmony among siblings", J Cell Sci, 117, pp.5965~5973 (2004)
- DiSepio D, "Characterization of loricrin regulation in vitro and in transgenic mice", Differentiation, 64, pp.225~235 (1999)
- Jang SI, "Activator protein 1activity is involved in the regulation of the cell type-specific expression from the proximal promoter of the human profilaggrin gene", J Biol Chem, 271, pp.24105~24114 (1996)
- Ng DC, "Requirement of an AP-1 site in the calcium response region of the involucrin promoter", J Biol Chem, 275, pp.24080~24088 (2000)